China Everbright raises $459m for BRI fund
China Everbright has reached a first close of RMB3 billion ($459 million) on an environment-focused fund that concentrates on economies covered by the Belt and Road Initiative (BRI).
The vehicle – which has an overall target of RMB10 billion – was launched in April. Hong Kong-listed China Everbright and its parent company China Everbright Group, as well as the China Everbright...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.